Immunogenicity 14436
Sample ID
3784
Response
Negative
Tumor Type
Melanoma
Gene Symbol
ZNF761
Transcript ID
NM_001008401
HLA INFO
B*07:01
TCR INFO
No TCR info found!
Full length protein sequence (746 aa)
MAFSQ
1
GLLTF
6
RDVAI
11
EFSQE
16
EWKCL
21
DPAQR
26
TLYRD
31
VMLEN
36
YRNLV
41
SLDIS
46
SKCTM
51
KEFLS
56
TAQGN
61
REVFH
66
AGTLQ
71
IHESH
76
HNGDF
81
CYQDV
86
DKDIH
91
DYEFQ
96
WQEDE
101
RNGHE
106
APMTK
111
IKKLT
116
GITER
121
YDQSH
126
ARNKP
131
IKDQL
136
GSSFH
141
SHLPE
146
MHIFQ
151
TEEKI
156
DNQVV
161
KSVHD
166
ASLVS
171
TAQRI
176
SCRPK
181
THISN
186
NHGNN
191
FWNSS
196
LLTQK
201
QEVHM
206
REKSF
211
QCNES
216
GKAFN
221
YSSLL
226
RKHQI
231
IHLAD
236
KYKCD
241
VCGKL
246
FNQKR
251
NLACH
256
RRCHT
261
GENPY
266
KCNEC
271
GKTFS
276
QTSSL
281
TCHRR
286
LHTGE
291
KPYKC
296
EECDK
301
AFHFK
306
SILER
311
HRIIH
316
TEEKP
321
YKCNE
326
CGKTF
331
RQKSI
336
LTRHH
341
RLHTG
346
EKPYK
351
CNECG
356
KTFSH
361
KSSLT
366
CHHRL
371
HTGEK
376
PYKCN
381
ECGKT
386
FSHKS
391
SLTCH
396
RRLHT
401
GEKPY
406
KCEEC
411
DKAYS
416
FRSNF
421
EIHRK
426
IHTED
431
NAYKC
436
NECGK
441
TFSRT
446
SSLTC
451
HRRRH
456
TGEQP
461
YKCEE
466
CDKAF
471
RFKSN
476
LERHR
481
RIHTG
486
EKPYK
491
CNECG
496
KTFSR
501
KSYLT
506
CHHRL
511
HTGEK
516
AYKCN
521
ECGKT
526
FSWKS
531
SLTCH
536
RRLHS
541
GEKPY
546
KCKEC
551
GKTFN
556
QQLTL
561
KRHRR
566
LHSGE
571
NPYKC
576
EDSDK
581
AYSFK
586
SNLEI
591
HQKIH
596
TEENP
601
YKCNE
606
CGKTF
611
SRTSS
616
LTCHR
621
RLHTG
626
EKPYK
631
CEECD
636
KAFRV
641
KSNLE
646
GHRRI
651
HTGEK
656
PYKCN
661
ECGKT
666
FSRKS
671
YFICH
676
HRLHT
681
GEKPY
686
KCNEC
691
GKNFS
696
QKSSL
701
ICHHR
706
LHTGE
711
KPYKC
716
NECGK
721
TFSQK
726
SNLTC
731
HRRLH
736
TGEKQ
741
V
746
Mutation Information
DNA mutation:
None
Peptide Range:
330 ~ 354
Mut AA position:
342 (13 in Wild Type peptide)
Alignment
Wild Type:
"ECGKTFRQKSILTRHHRLHTGEKPY
||||||||||||.||||||||||||
Mutant:
ECGKTFRQKSILIRHHRLHTGEKPY"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) ZNF761
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay